The transmission of dengue virus (DENV) from an infected Aedes mosquito to a human,
causes illness ranging from mild dengue fever to fatal dengue shock syndrome. The similar …

Dengue is a highly endemic infectious disease of the tropical countries and is rapidly
becoming a global burden. It is caused by any of the 4 serotypes of dengue virus and is …

Dengue poses a global health threat, which will persist without therapeutic intervention.
Immunity induced by exposure to one serotype does not confer long-term protection against …

It is easy to argue that vaccine development represents humankind's most important and
successful endeavour, such is the impact that vaccination has had on human morbidity and …

The timelines for developing vaccines against infectious diseases are lengthy, and often
vaccines that reach the stage of large phase 3 field trials fail to provide the desired level of …

Dengue is an emerging mosquito‐borne viral infection with increasing reports of outbreaks.
The clinical picture ranges from a benign febrile illness through to severe and potentially …

Dengue virus has emerged as an important arboviral infection worldwide. As a complex
pathogen, with four distinct serotypes, the development of a successful Dengue virus …

Dengue is one of the most frequently transmitted mosquito-borne diseases in the world,
which creates a significant public health concern globally, especially in tropical and …

Recombinant proteins are gaining enormous importance these days due to their wide
application as biopharmaceutical products and proven safety record. Various recombinant …

Background Dengue is the most common mosquito-borne viral disease in human beings,
and vector control has not halted its spread worldwide. A dengue vaccine for individuals …